These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33987873)

  • 1. Positive airway pressure (PAP) treatment reduces glycated hemoglobin (HbA1c) levels in obstructive sleep apnea patients with concomitant weight loss: Longitudinal data from the ESADA.
    Tasbakan MS; Grote L; Hedner J; Kvamme JA; Verbraecken J; McNicholas WT; Roisman G; Tkacova R; Bonsignore MR; Saaresranta T; Steiropoulos P; Marrone O; Basoglu OK;
    J Sleep Res; 2021 Oct; 30(5):e13331. PubMed ID: 33987873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Continuous Positive Airway Pressure on glycated hemoglobin in patients with type 2 diabetes and Obstructive Sleep Apnea.
    Gharsalli H; Oueslati I; Sahnoun I; Neffati O; Ghrairi N; Maalej S; Douik El Gharbi L
    Tunis Med; 2019 Dec; 97(12):1345-1352. PubMed ID: 32173803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive airway pressure normalizes glucose metabolism in obstructive sleep apnea independent of diabetes and obesity.
    Kabeloğlu V; Senel GB; Karadeniz D
    Ideggyogy Sz; 2020 Nov; 73(11-12):417-425. PubMed ID: 33264533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term positive airway pressure therapy is associated with reduced total cholesterol levels in patients with obstructive sleep apnea: data from the European Sleep Apnea Database (ESADA).
    Gunduz C; Basoglu OK; Kvamme JA; Verbraecken J; Anttalainen U; Marrone O; Steiropoulos P; Roisman G; Joppa P; Hein H; Trakada G; Hedner J; Grote L;
    Sleep Med; 2020 Nov; 75():201-209. PubMed ID: 32858361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Change in weight and central obesity by positive airway pressure treatment in obstructive sleep apnea patients: longitudinal data from the ESADA cohort.
    Basoglu OK; Zou D; Tasbakan MS; Hedner J; Ryan S; Verbraecken J; Escourrou P; Antalainen U; Kvamme JA; Bonsignore MR; Schiza S; Grote L;
    J Sleep Res; 2018 Dec; 27(6):e12705. PubMed ID: 29797754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstructive sleep apnoea and 12-month weight loss in adults with class 3 obesity attending a multidisciplinary weight management program.
    Kobuch S; Tsang F; Chimoriya R; Gossayn D; O'Brien S; Jamal J; Laks L; Tahrani A; Kormas N; Piya MK
    BMC Endocr Disord; 2021 Nov; 21(1):227. PubMed ID: 34774056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Controlled Trial of Continuous Positive Airway Pressure on Glucose Tolerance in Obese Patients with Obstructive Sleep Apnea.
    Salord N; Fortuna AM; Monasterio C; Gasa M; Pérez A; Bonsignore MR; Vilarrasa N; Montserrat JM; Mayos M
    Sleep; 2016 Jan; 39(1):35-41. PubMed ID: 26350474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical Activity Following Positive Airway Pressure Treatment in Adults With and Without Obesity and With Moderate-Severe Obstructive Sleep Apnea.
    Feng Y; Maislin D; Keenan BT; Gislason T; Arnardottir ES; Benediktsdottir B; Chirinos JA; Townsend RR; Staley B; Pack FM; Sifferman A; Pack AI; Kuna ST
    J Clin Sleep Med; 2018 Oct; 14(10):1705-1715. PubMed ID: 30353806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of sleep apnea severity on glycemic control in patients with type 2 diabetes prior to continuous positive airway pressure treatment.
    Pillai A; Warren G; Gunathilake W; Idris I
    Diabetes Technol Ther; 2011 Sep; 13(9):945-9. PubMed ID: 21714680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Continuous Positive Airway Pressure on Glycemic Control in Patients with Obstructive Sleep Apnea and Type 2 Diabetes. A Randomized Clinical Trial.
    Martínez-Cerón E; Barquiel B; Bezos AM; Casitas R; Galera R; García-Benito C; Hernanz A; Alonso-Fernández A; Garcia-Rio F
    Am J Respir Crit Care Med; 2016 Aug; 194(4):476-85. PubMed ID: 26910598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous Positive Airway Pressure Treatment, Glycemia, and Diabetes Risk in Obstructive Sleep Apnea and Comorbid Cardiovascular Disease.
    Loffler KA; Heeley E; Freed R; Meng R; Bittencourt LR; Gonzaga Carvalho CC; Chen R; Hlavac M; Liu Z; Lorenzi-Filho G; Luo Y; McArdle N; Mukherjee S; Yap HS; Zhang X; Palmer LJ; Anderson CS; McEvoy RD; Drager LF;
    Diabetes Care; 2020 Aug; 43(8):1859-1867. PubMed ID: 32291275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial.
    Blackman A; Foster GD; Zammit G; Rosenberg R; Aronne L; Wadden T; Claudius B; Jensen CB; Mignot E
    Int J Obes (Lond); 2016 Aug; 40(8):1310-9. PubMed ID: 27005405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Treatment of OSA With CPAP on Glycemic Control in Adults With Type 2 Diabetes: The Diabetes Sleep Treatment Trial (DSTT).
    Chasens ER; Korytkowski M; Burke LE; Strollo PJ; Stansbury R; Bizhanova Z; Atwood CW; Sereika SM
    Endocr Pract; 2022 Apr; 28(4):364-371. PubMed ID: 35131440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CPAP therapy for patients with sleep apnea and type 2 diabetes mellitus improves control of blood pressure.
    Lam JCM; Lai AYK; Tam TCC; Yuen MMA; Lam KSL; Ip MSM
    Sleep Breath; 2017 May; 21(2):377-386. PubMed ID: 27817148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a lifestyle intervention on REM sleep-related OSA severity in obese individuals with type 2 diabetes.
    Shechter A; Foster GD; Lang W; Reboussin DM; St-Onge MP; Zammit G; Newman AB; Millman RP; Wadden TA; Jakicic JM; Strotmeyer ES; Wing RR; Pi-Sunyer FX; Kuna ST;
    J Sleep Res; 2017 Dec; 26(6):747-755. PubMed ID: 28560832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Treatment of Obstructive Sleep Apnea on Glycemic Control in Type 2 Diabetes.
    Shaw JE; Punjabi NM; Naughton MT; Willes L; Bergenstal RM; Cistulli PA; Fulcher GR; Richards GN; Zimmet PZ
    Am J Respir Crit Care Med; 2016 Aug; 194(4):486-92. PubMed ID: 26926656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of positive airway pressure therapy on seizure control in patients with epilepsy and obstructive sleep apnea.
    Pornsriniyom D; Kim Hw; Bena J; Andrews ND; Moul D; Foldvary-Schaefer N
    Epilepsy Behav; 2014 Aug; 37():270-5. PubMed ID: 25117208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of CPAP on arterial stiffness in severely obese patients with obstructive sleep apnoea.
    Seetho IW; Asher R; Parker RJ; Craig S; Duffy N; Hardy KJ; Wilding JP
    Sleep Breath; 2015 Dec; 19(4):1155-65. PubMed ID: 25655633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised, cOntrolled Multicentre trial of 26 weeks subcutaneous liraglutide (a glucagon-like peptide-1 receptor Agonist), with or without contiNuous positive airway pressure (CPAP), in patients with type 2 diabetes mellitus (T2DM) and obstructive sleep apnoEa (OSA) (ROMANCE): study protocol assessing the effects of weight loss on the apnea-hypnoea index (AHI).
    Sprung VS; Kemp GJ; Wilding JP; Adams V; Murphy K; Burgess M; Emegbo S; Thomas M; Needham AJ; Weimken A; Schwab RJ; Manuel A; Craig SE; Cuthbertson DJ
    BMJ Open; 2020 Jul; 10(7):e038856. PubMed ID: 32699168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms of insomnia among patients with obstructive sleep apnea before and after two years of positive airway pressure treatment.
    Björnsdóttir E; Janson C; Sigurdsson JF; Gehrman P; Perlis M; Juliusson S; Arnardottir ES; Kuna ST; Pack AI; Gislason T; Benediktsdóttir B
    Sleep; 2013 Dec; 36(12):1901-9. PubMed ID: 24293765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.